$LXXGF News

Last published 3y ago

3y agoLXXGFLexaGene Files for Chapter 7 BankruptcyGlobeNewswireBEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), announces that it has ceased operations, laid off its staff, and, together with its
3y agoLXXGFLexaGene Provides Update on BioPharma SectorGlobeNewswireBEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the
3y agoLXXGFLexaGene's MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma CustomersGlobeNewswireBEVERLY, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLabTM System
3y agoLXXGFBioPharma Engages LexaGene in Second Feasibility StudyGlobeNewswireBEVERLY, Mass. , Dec. 16, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab®
3y agoLXXGFLexaGene Holdings Proposes to Amend Warrants TermsGlobeNewswireBEVERLY, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab®
3y agoLXXGFLexaGene Successfully Completes Statement of Work for BioPharma CompanyGlobeNewswireBEVERLY, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab®
4y agoLXXGFLexaGene Closes Secured Convertible Note TransactionGlobeNewswireBEVERLY, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab® System for
4y agoLXXGFLarge Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology ValidationGlobeNewswireBEVERLY, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab®
4y agoLXXGFLexaGene Receives Signed Quote from Large Biopharma Company to Purchase a MiQLab SystemGlobeNewswireBEVERLY, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab®
4y agoLXXGFLexaGene Announces MiQLab® System Sale to Veterinary Hospital in CaliforniaGlobeNewswireBEVERLY, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic testing,
4y agoLXXGFLexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be DeclaredGlobeNewswireBEVERLY, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic testing,
4y agoLXXGFLexaGene's MiQLab System Generates Leptospira Results in as Soon as 30 minutes using Isothermal ChemistryGlobeNewswireBEVERLY, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic syndromic
4y agoLXXGFUniversity of Pennsylvania's School of Veterinary Medicine to Evaluate New Gastrointestinal Panel Using LexaGene's MiQLab SystemGlobeNewswireBEVERLY, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic syndromic
4y agoLXXGFLexaGene Reduces Time-to-Result by ~35%GlobeNewswireBEVERLY, Mass., Aug. 10, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based syndromic testing in
4y agoLXXGFLexaGene Announces Filing of Financial Statements, Revocation of MCTO & the Granting of Incentive Equity Awards to EmployeesGlobeNewswireBEVERLY, Mass., July 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based syndromic testing in
4y agoLXXGFLexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract InfectionsGlobeNewswireBEVERLY, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based syndromic testing in
4y agoLXXGFLexaGene Provides MCTO UpdateGlobeNewswireBEVERLY, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based syndromic testing in
4y agoLXXGFLexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract InfectionsGlobeNewswireBEVERLY, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab System for automated, multiplexing PCR-based syndromic
4y agoLXXGFLexaGene Announces MiQLab® System Sale to Veterinary Hospital in WisconsinGlobeNewswireBEVERLY, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab® System for automated, multiplexing PCR-based syndrom
4y agoLXXGFLexaGene Announces Management Cease Trade OrderGlobeNewswireBEVERLY, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company") announces, further to its news release on June 28, 2022, the Company has been granted a management cease trade order ("MCT
4y agoLXXGFLexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial FilingsGlobeNewswireBEVERLY, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company") announces that it has filed an initial registration statement with the United States Securities and Exchange Commission (the
4y agoLXXGFLexaGene Announces Multi-System Purchase from a Large Market Leader in Animal HealthGlobeNewswireBEVERLY, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to a
4y agoLXXGFLexaGene Successfully Completes CRADA with US ArmyGlobeNewswireBEVERLY, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab® System, a fully automated rapid pathogen testing dev
4y agoLXXGFLexaGene Announces Multi-System Purchase from a Corporate Veterinary Reference LaboratoryGlobeNewswireBEVERLY, Mass., April 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to
4y agoLXXGFLexaGene Announces Results of Annual General and Special MeetingGlobeNewswireBEVERLY, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSXV:LXG, OTCQB:LXXGF) (the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to announce the
4y agoLXXGFLexaGene Closes Multiple MiQLab SalesGlobeNewswireBEVERLY, Mass., Dec. 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSXV:LXG, OTCQB:LXXGF) (the "Company"), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce two purchase ord
4y agoLXXGFLexaGene Intends to Pursue Full Panel Pathogen Testing through the FDAGlobeNewswireBEVERLY, Mass., Nov. 24, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, today announc
4y agoLXXGFLeading Veterinary Academic, Dr. Jane Sykes, Joins LexaGene Board of DirectorsGlobeNewswireBEVERLY, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, today announc
5y agoLXXGFLexaGene Expands Bio-Pharma Contamination Panel by Adding Test that includes a Biothreat AgentGlobeNewswireBEVERLY, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, today announced it has success
5y agoLXXGFLexaGene Receives 2021 BioTech Breakthrough AwardGlobeNewswireBEVERLY, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary
5y agoLXXGFLexaGene Finalizes Design of Pneumonia PanelGlobeNewswireBEVERLY, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary
5y agoLXXGFLexaGene Completes First Stage of U.S. ARMY DEVCOM AgreementGlobeNewswireBEVERLY, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, today announc
5y agoLXXGFLexaGene's MiQLab™ System Selected to be a Best in Show Spotlight at the 47th Annual Industry Petcare Innovation SummitGlobeNewswireBEVERLY, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary
5y agoLXXGFLexaGene to Host Corporate Update on November 3GlobeNewswireBEVERLY, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary
5y agoLXXGFLexaGene Completes Analytical Studies for FDA EUA of COVID-19 TestingGlobeNewswireBEVERLY, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary
5y agoALVOF AMPDF DKLRF DYFSF+8Small Cap Growth Investor Presentations Now Available for On-Demand ViewingPR NewswireNEW YORK, Oct. 11, 2021 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the October 7th Small Cap Growth Virtual Investor Conference are now available for on-demand
5y agoLXXGFLexaGene's Largest Study Validates Accuracy of its Veterinary Test PanelGlobeNewswireTechnology Accurately Identifies Pathogens and Predicts Antimicrobial Resistance In less than 30 years, drug resistant bacteria are predicted to kill 3 times more people on an annual basis than COVID-19 did in 2020 MiQLab is a diagnostic tool use
5y agoLXXGFLexaGene to Webcast Live at VirtualInvestorConferences.com October 7thPR NewswireBEVERLY, Mass., Oct. 6, 2021 /PRNewswire/ -- LexaGene Holdings, Inc., ((LXXGF, LXG) ("LexaGene" or the "Company"), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results in approximately t
5y agoLXXGFLexaGene Expands Brand Awareness at Key Investor ConferencesGlobeNewswireBEVERLY, Mass., Oct. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results i
5y agoALVOD AMPDF DKLRF DYFSF+9Live Investor Conference & Webinar: Small Cap Growth Conference on October 7thPR NewswireNEW YORK, Sept. 30, 2021 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Small Cap Growth Virtual Investor Conference. Individual investors, institutional inv
5y agoLXXGFLexaGene Reports on Recent Veterinary Trade ShowsGlobeNewswireBEVERLY, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results
5y agoLXXGFLexaGene Enters into Cooperative Research and Development Agreement with the United States Army's Combat Capabilities Development CommandGlobeNewswireBEVERLY, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSXV:LXG, OTCQB:LXXGF) (the "Company"), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it has entered
5y agoLXXGFLexaGene's MiQLab™ Accurately Detects Multiple Strains of Pathogenic Bacteria in Polymicrobial Samples Compared to Conventional CultureGlobeNewswireMiQLab detected both bacterial strains in polymicrobial samples in ~2 hours Culture and Sensitivity Testing (C&ST) failed to detect the minor pathogen population in individual mixed samples, with final test results taking up to 11 days MiQLab testing
5y agoLXXGFLexaGene's MiQLab™ System Featured at Three Key Veterinary TradeshowsGlobeNewswireSeptember 7-9, WVC 93rd Annual Conference, Las Vegas, NV September 12-14, International Veterinary Emergency and Critical Care, Nashville, TN September 23-26, Southwest Veterinary Symposium, San Antonio, TX BEVERLY, Mass., Sept. 03, 2021 (
5y agoLXXGFLexaGene Demonstrates a Simple and Inexpensive Multiplex PCR Chemistry with Shorter Lead Times for use on its MiQLab SystemGlobeNewswireFirst point-of-need, PCR system capable of using conventional probe-based chemistry or inexpensive, rapidly available SYBR Green chemistry BEVERLY, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) a molecula
5y agoAREC AURQF AZASF BIOC+22Proactive news headlines including American Resources, Nextleaf Solutions, Versus Systems and Vox RoyaltyGlobeNewswireNew York , July 20, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Arizona Silver Exploration Inc (CVE:AZS) (OTC:AZASF) h
5y agoLXXGFLexaGene's MiQLab Detects Common Bioreactor Contaminant up to 300 Times Faster than Conventional MethodsGlobeNewswireMycoplasmas are thought to contaminate 15-80% of cell cultures worldwide MiQLab rapidly detected 100% of the tested mycoplasma samples within two hours, with no false positives MiQLab can be used inside biopharmaceutical manufacturers to rapidly valid
5y agoAUSAF BRGGF CAMZF CDXFF+19Proactive news headlines including VR Resources, Dalrada Corp, Cloud DX and Kenorland MineralsGlobeNewswireNew York , July 14, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies TNR Gold Corp (CVE:TNR) (OTC:TRRXF) (FRA:TNW) says report
5y agoLXXGFLexaGene Retains Wolf Greenfield Intellectual Property Law FirmGlobeNewswireBEVERLY, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) (the "Company"), a molecular diagnostics company that develops a fully automated rapid pathogen detection system, today announced its strategic relation
5y agoACER ATGN BASA BKTI+1650+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021ACCESS NewswireRALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the thr